Combination therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9415043
SERIAL NO

14213961

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are compounds and compositions for treating glaucoma and/or reducing intraocular pressure. Compositions may comprise an isoquinoline compound and a prostaglandin or a prostaglandin analog. Compounds described herein include those in which an isoquinoline compound is covalently linked to a prostaglandin or a prostaglandin analog, and those in which an isoquinoline compound and a prostaglandin free acid together form a salt.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALCON INCRUE LOUIS-D' AFFRY 6 FRIBOURG 1701

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
deLong, Mitchell A Chapel Hill, US 102 2084
Kopczynski, Casey Chapel Hill, US 31 489
Lin, Cheng-Wen Raleigh, US 39 468
Sturdivant, Jill Marie Chapel Hill, US 49 1601

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 16, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00